In our study, we found that CD160 was the most significant co-signaling gene aberrantly expressed in autoimmune diseases, while several widely-studied co-signaling genes, such as ICOS, PD1 and CLTA4, were not identified as significant genes in the RRA analysis. The gene discussed is CD160; the disease is autoimmune disease.